Nationally there is a trend moving towards radial artery access versus femoral artery access for endovascular procedures, and Q'Apel Medical is leading the way.

Q'Apel Medical Welcomes Thomas Berryman, Chief Financial Officer

New 35,000 square foot Facility will support the company's growth and OUS expansion

Additional cleanroom for catheter manufacturing, assemblies, and components

Q'Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International

Newest kit innovation expands commitment to continuous vascular access improvements

Semprus BioSciences today announced the appointment of Alonzo (Lon) D. Cook, Ph.D., to the newly-created post of Group Leader, Research, effective immediately.

A study presented at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), showed a novel agent served as both an antimicrobial and anti-coagulation activity.

Over 300,000 patients suffering from stroke and multiple sclerosis or spinal cord injuries resulting in quadriplegia or paraplegia use Foley catheters. These patients are at a daily risk for developing catheter-associated urinary tract infections.